Data / Form D filings / ARCA biopharma, Inc.
ARCA biopharma, Inc.: Form D filings
ARCA biopharma, Inc., a pharmaceuticals company in Westminster, CO, filed 8 Form D notices with the SEC between 2009 and 2015. The latest, on June 25, 2015, reports $51.7 million sold of a $51.7 million offering to 14 investors.
Find out what ARCA biopharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11080 CIRCLEPOINT ROAD, SUITE 140, Westminster, CO, 80020
- Phone
- (720) 940-2200
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 907654
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 25, 2015 | New notice | $51,650,404 | $51,650,404 | $0 | 14 | Jun 16, 2015 | sec.gov |
| Feb 20, 2014 | New notice | $326,158 | $326,158 | $0 | 2 | Feb 7, 2014 | sec.gov |
| Jun 17, 2013 | New notice | $1,250,000 | $1,250,000 | $0 | 2 | Jun 4, 2013 | sec.gov |
| Feb 1, 2013 | New notice | $1,000,000 | $1,000,000 | $0 | 5 | Jan 25, 2013 | sec.gov |
| Dec 28, 2012 | New notice | $250,000 | $250,000 | $0 | 1 | Dec 18, 2012 | sec.gov |
| Oct 31, 2012 | New notice | $325,000 | $325,000 | $0 | 4 | Oct 22, 2012 | sec.gov |
| Jan 5, 2012 | New notice | $4,549,285 | $4,549,285 | $0 | 6 | Dec 22, 2011 | sec.gov |
| Oct 26, 2009 | New notice | $499,999 | $499,999 | $0 | 1 | Oct 18, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher D. Ozeroff | Executive Officer | |
| Thomas A. Keuer | Executive Officer | |
| Raymond L. Woosley | Director | |
| Linda S. Grais | Director | |
| Dan J. Mitchell | Director | |
| Brian L. Selby | Executive Officer | |
| Robert E. Conway | Director | |
| Michael R. Bristow | Executive Officer, Director |
Every Form D from the week of Jun 22, 2015 · All recent filings in Colorado · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ARCA biopharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.